ADMA BIOLOGICS, INC. (ADMA) › Operating IncomeADMA BIOLOGICS, INC. (ADMA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$4.62M2012: -$7.91M2013: -$15.04M2014: -$16.02M2015: -$15.51M2016: -$17.33M2017: -$39.31M2018: -$60.29M2019: -$41.42M2020: -$64.91M2021: -$58.37M2022: -$39.37M2023: $21.63M2024: $138.98M2025: $191.44M$191.44M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$191.44M+37.7%2024$138.98M+542.5%2023$21.63M+155.0%2022-$39.37M+32.6%2021-$58.37M+10.1%2020-$64.91M-56.7%2019-$41.42M+31.3%2018-$60.29M-53.4%2017-$39.31M-126.8%2016-$17.33M-11.7%2015-$15.51M+3.2%2014-$16.02M-6.5%2013-$15.04M-90.2%2012-$7.91M-71.1%2011-$4.62M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share